Circulating Tumor Cells & Multiple Myeloma Treatment Outcomes
A new study is offering further evidence that a four-drug combination including daratumumab is significantly improving outcomes for patients with newly diagnosed multiple myeloma, particularly those ineligible for or deferring … Read More